H

HUTCHMED (China) Ltd
HKEX:13

Watchlist Manager
HUTCHMED (China) Ltd
HKEX:13
Watchlist
Price: 24.4 HKD 1.24% Market Closed
Market Cap: 21.3B HKD

Intrinsic Value

The intrinsic value of one HUTCHMED (China) Ltd stock under the Base Case scenario is 31.19 HKD. Compared to the current market price of 24.4 HKD, HUTCHMED (China) Ltd is Undervalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
31.19 HKD
Undervaluation 22%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
HUTCHMED (China) Ltd

HUTCHMED (China) Ltd
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for HUTCHMED (China) Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

HUTCHMED (China) Ltd
HKEX:13
HK
Pharmaceuticals
Market Cap
21.3B HKD
IPO
May 19, 2006
HK
Pharmaceuticals
Market Cap
21.3B HKD
IPO
May 19, 2006
Price
HK$false
EPS
$false
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HUTCHMED (China) Ltd?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about HUTCHMED (China) Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
HUTCHMED (China) Ltd

Current Assets 1B
Cash & Short-Term Investments 802.5m
Receivables 192.3m
Other Current Assets 53.5m
Non-Current Assets 212.6m
Long-Term Investments 80.5m
PP&E 94.8m
Other Non-Current Assets 37.3m
Efficiency

Free Cash Flow Analysis
HUTCHMED (China) Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
HUTCHMED (China) Ltd

Revenue
610.8m USD
Cost of Revenue
-356.3m USD
Gross Profit
254.5m USD
Operating Expenses
-375.3m USD
Operating Income
-120.8m USD
Other Expenses
78.8m USD
Net Income
-42m USD
Fundamental Scores

Profitability Score
Profitability Due Diligence

HUTCHMED (China) Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

29/100
Profitability
Score

HUTCHMED (China) Ltd's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

HUTCHMED (China) Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Negative Net Debt
Low D/E
Short-Term Solvency
80/100
Solvency
Score

HUTCHMED (China) Ltd's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
HUTCHMED (China) Ltd

Wall Street analysts forecast HUTCHMED (China) Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HUTCHMED (China) Ltd is 37.97 HKD with a low forecast of 27.37 HKD and a high forecast of 53.9 HKD.

Lowest
Price Target
27.37 HKD
12% Upside
Average
Price Target
37.97 HKD
56% Upside
Highest
Price Target
53.9 HKD
121% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

HUTCHMED (China) Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for HUTCHMED (China) Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

News

Other Videos
What is the Intrinsic Value of one HUTCHMED (China) Ltd stock?

The intrinsic value of one HUTCHMED (China) Ltd stock under the Base Case scenario is 31.19 HKD.

Is HUTCHMED (China) Ltd stock undervalued or overvalued?

Compared to the current market price of 24.4 HKD, HUTCHMED (China) Ltd is Undervalued by 22%.

Back to Top